Resistant hypertension in patients with chronic aortic dissection

Journal of Human Hypertension

Volumn 19, Issue 3, 2005, Pages 227-231

  Eggebrecht, Holger ^a   Schmermund, A ^a   von Birgelen, C ^b   Naber, C K ^a   Bartel, T ^a   Wenzel, R R ^a   Erbel, R ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

blocker; Aortic dissection; Blood pressure; Hypertension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMIDAZOLINE;

ADULT; AGED; AORTA DISSECTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CHI SQUARE TEST; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MALE; MEDICAL RECORD; OBESITY; PRESCRIPTION; SYSTOLIC BLOOD PRESSURE; TREATMENT FAILURE;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; ANEURYSM, DISSECTING; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; AORTIC ANEURYSM; AORTOGRAPHY; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CHRONIC DISEASE; DIURETICS; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SYMPATHOLYTICS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE;

EID: 14944341043     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001800     Document Type: Article

References (15)

1. Bernard Y et al. False lumen patency as a predictor of late outcome in aortic dissection. Am J Cardiol 2001; 87: 1378-1382.
2. Juvonen T et al. Risk factors for rupture of chronic type-B dissections. J Thorac Cardiovasc Surg 1999; 117: 776-784.
3. Wheat MW, Palmer RF, Bartley TD, Seelman RC. Treatment of dissecting aneurysms of the aorta without surgery. J Thorac Cardiovasc Surg 1965; 50: 364-373.
4. Erbel R et al. Diagnosis and management of aortic dissection. Eur Heart J 2001; 22: 1642-1681.
5. Januzzi JL et al. Refractory systemic hypertension following type B aortic dissection. Am J Cardiol 2001; 88: 686-688.
6. Grajek S et al. Results of long-term medical treatment of patients with arterial hypertension complicated by aortic dissection. J Hum Hypertens 1995; 9: 987-992.
7. Crawford ES et al. Surgical treatment of aneurysm and/or dissection of the ascending aorta, transverse aortic arch, and ascending aorta and transverse aortic arch. Factors influencing survival in 717 patients. J Thorac Cardiovasc Surg 1989; 98(Part 1): 659-673.
8. Chalmers J et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines subcommittee of the World Health Organization. Clin Exp Hypertens 1999; 21: 1009-1060.
9. Amar J et al. Why is hypertension so frequently uncontrolled in secondary prevention? J Hypertens 2003; 21: 1199-1205.
10. Rackson ME, Lossef SV, Sos TA. Renal artery stenosis in patients with aortic dissection: increased prevalence. Radiology 1990; 177: 555-558.
11. Wagner A et al. Plasma endothelin in patients with acute aortic disease. Resuscitation 2002; 53: 71-76.
12. Nienaber CA, Eagle KA. Aortic dissection: new frontiers in diagnosis and management: part I: from etiology to diagnostic strategies. Circulation 2003; 108: 628-635.
13. Genoni M et al. Chronic beta-blocker therapy improves outcome and reduces treatment costs in chronic type b aortic dissection. Eur J Cardiothorac Surg 2001; 19: 606-610.
14. Gadowski GR, Pilcher DB, Ricci MA. Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade. J Vasc Surg 1994; 19: 727-731.
15. Brophy CM, Tilson JE, Tilson MD. Propranolol stimulates the crosslinking of matrix components in skin from the aneurysm prone Blotchy mouse. J Surg Res 1989; 46: 330-332.